David Crean

Cardiff By The Sea, California, United States
David has +25 years buy- and sell-side expertise of M&A, partnering and investments within life sciences and healthcare working within strategic biopharma companies, private equity, investment banking and venture capital. He is the Managing General Partner of Equitos Venture Partners LLC, an emerging life sciences-focused investment fund. In parallel to Equitos, he is a limited partner for Suncoast Ventures and Mesa Verde Venture Partners, two life sciences venture funds focused on incubator through growth-stage companies. Aside from his venture investment activities, he serves as Managing General Partner for Cardiff Advisory LLC, a boutique mergers & acquisitions investment banking and strategic advisory firm focused on life sciences and healthcare companies. Through his Cardiff Advisory affiliation, he serves in fractional CEO and CBO roles for a few private and public companies.

David currently serves in leading Boards of Director roles for Histogen, Inc. (Nasdaq: HSTO) as Lead Independent Director, Phoenix Molecular Designs as Board Chairman, an Independent Board Member for Paracrine Inc., on the Executive Committee and Board for California Life Sciences (CLS), and BIOCOM California’s Board of Governors as Chair of Capital Development. David is an active member of the Association for Corporate Growth (ACG) and served as President for the past two years of the San Diego, CA chapter, is active member of CEO’s Against Cancer for the American Cancer Society, and serves as Chairman of the Board for the Alzheimer’s Association for San Diego/ Imperial Counties.

David holds FINRA Series 79 and Series 63 licenses and is a Registered Investment Banking Representative of BA Securities LLC, Member FINRA SIPC. He holds a Doctorate of Philosophy (Ph.D.) Degree in Biophysics and a Masters of Science (MS) Degree in Oncology from the State University of New York at Buffalo. He earned a Bachelor of Science (BS) Degree in Biology/ Pre-Med from Canisius College. Additionally, he holds a Masters of Business Administration (MBA) Degree with a finance concentration from Pepperdine University Graziadio School of Management.
Speaking In
11:00 AM - 12:00 PM (PDT)
Wednesday, June 15
Do you have what it takes to entice the industry’s top investors? Bring your A-game as you…